Factors that affect postnatal bone growth retardation in the twitcher murine model of Krabbe disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1802, Issue 7-8, 2010, Pages 601-608

  Contreras, Miguel Agustin ^a   Ries, William Louis ^a   Shanmugarajan, Srinivasan ^a   Arboleda, Gonzalo ^a   Singh, Inderjit ^b   Singh, Avtar Kaur ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Galactosylsphingosine; Insulin like growth factor 1; Krabbe disease; Lysosomal disorders; Osteopenia; Psychosine; Twitcher mice

Indexed keywords

CERAMIDE; INTERLEUKIN 6; MESSENGER RNA; PSYCHOSINE; SOMATOMEDIN C; SPHINGOLIPID; SPHINGOSINE 1 PHOSPHATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DISEASE; BONE GROWTH; BONE MARROW; CELL DEATH; CONTROLLED STUDY; FEMUR; GLOBOID CELL LEUKODYSTROPHY; GROWTH RETARDATION; HOMEOSTASIS; LIVER; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLAST ACTIVITY; POSTNATAL GROWTH; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; ANIMALS, NEWBORN; BONE DEVELOPMENT; BONE DISEASES, DEVELOPMENTAL; BONE REMODELING; CYTOKINES; DISEASE MODELS, ANIMAL; INSULIN-LIKE GROWTH FACTOR I; LEUKODYSTROPHY, GLOBOID CELL; LIVER; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PSYCHOSINE; RISK FACTORS;

ANIMALIA; MURINAE; MUS;

EID: 77953808861     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.04.006     Document Type: Article

References (73)

1. Wenger D.A., Suzuki K., Suzuki Y., Suzuki K. Galactosylceramide lipidosis: globoid cell leukodystrophy (Krabbe disease). The Metabolic & Molecular Bases of Inherited Disease 2001, 3669-3694. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
2. Kolodny E.H. Globoid leukodystrophy. Handbook of Clinical Neurology: Neurodystrophies and Neurolipidoses 1996, 187-210. Elsevier, Amsterdam. P.J. Vinken, G.W. Bruyn (Eds.).
3. Igisu H., Suzuki K. Progressive accumulation of toxic metabolite in a genetic leukodystrophy. Science 1984, 224:753-755.
4. Kobayashi T., Shinoda H., Goto I., Yamanaka T., Suzuki Y. Globoid cell leukodystrophy is a generalized galactosylsphingosine (psychosine) storage disease. Biochem. Biophys. Res. Commun. 1987, 144:41-46.
5. Suzuki K. The twitcher mouse. A model of human globoid cell leukodystrophy (Krabbe's disease). Am. J. Pathol. 1983, 111:394-397.
6. Tanaka K., Webster H.D. Effects of psychosine (galactosylsphingosine) on the survival and the fine structure of cultured Schwann cells. J. Neuropathol. Exp. Neurol. 1993, 52:490-498.
7. Ohno M., Komiyama A., Martin P.M., Suzuki K. MHC class II antigen expression and T-cell infiltration in the demyelinating CNS and PNS of the twitcher mouse. Brain Res. 1993, 625:186-196.
8. LeVine S.M., Brown D.C. IL-6 and TNFalpha expression in brains of twitcher, quaking and normal mice. J. Neuroimmunol. 1997, 73:47-56.
9. Taniike M., Marcus J.R., Popko B., Suzuki K. Expression of major histocompatibility complex class I antigens in the demyelinating twitcher CNS and PNS. J. Neurosci. Res. 1997, 47:539-546.
10. Itoh M., Hayashi M., Fujioka Y., Nagashima K., Morimatsu Y., Matsuyama H. Immunohistological study of globoid cell leukodystrophy. Brain Dev. 2002, 24:284-290.
11. Haq E., Giri S., Singh I., Singh A.K. Molecular mechanism of psychosine-induced cell death in human oligodendrocyte cell line. J. Neurochem. 2003, 86:1428-1440.
12. Zaka M., Wenger D.A. Psychosine-induced apoptosis in a mouse oligodendrocyte progenitor cell line is mediated by caspase activation. Neurosci. Lett. 2004, 358:205-209.
13. Giri S., Jatana M., Rattan R., Won J.S., Singh I., Singh A.K. Galactosylsphingosine (psychosine)-induced expression of cytokine-mediated inducible nitric oxide synthases via AP-1 and C/EBP: implications for Krabbe disease. FASEB J. 2002, 16:661-672.
14. Jatana M., Giri S., Singh A.K. Apoptotic positive cells in Krabbe brain and induction of apoptosis in rat C6 glial cells by psychosine. Neurosci. Lett. 2002, 330:183-187.
15. Taniike M., Mohri I., Eguchi N., Irikura D., Urade Y., Okada S., et al. An apoptotic depletion of oligodendrocytes in the twitcher, a murine model of globoid cell leukodystrophy. J. Neuropathol. Exp. Neurol. 1999, 58:644-653.
16. Matsushima G.K., Taniike M., Glimcher L.H., Grusby M.J., Frelinger J.A., Suzuki K., et al. Absence of MHC class II molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophy. Cell 1994, 78:645-656.
17. Tanaka K., Nagara H., Kobayashi T., Goto I. The twitcher mouse: accumulation of galactosylsphingosine and pathology of the sciatic nerve. Brain Res. 1988, 454:340-346.
18. Jacobs J.M., Scaravilli F., De Aranda F.T. The pathogenesis of globoid cell leucodystrophy in peripheral nerve of the mouse mutant twitcher. J. Neurol. Sci. 1982, 55:285-304.
19. Kaplan S.L. Hormonal regulation of growth and metabolic effects of growth hormone. Handbook of Physiology: The Endocrine System 1999, 129-143. Oxford University Press, New York. J.L. Kostyo (Ed.).
20. Isaksson O.G., Jansson J.O., Gause I.A. Growth hormone stimulates longitudinal bone growth directly. Science 1982, 216:1237-1239.
21. Reinecke M., Schmid A.C., Heyberger-Meyer B., Hunziker E.B., Zapf J. Effect of growth hormone and insulin-like growth factor I (IGF-I) on the expression of IGF-I messenger ribonucleic acid and peptide in rat tibial growth plate and articular chondrocytes in vivo. Endocrinology 2000, 141:2847-2853.
22. Carter-Su C., Schwartz J., Smit L.S. Molecular mechanism of growth hormone action. Annu. Rev. Physiol. 1996, 58:187-207.
23. Mathews L.S., Norstedt G., Palmiter R.D. Regulation of insulin-like growth factor I gene expression by growth hormone. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:9343-9347.
24. Baker J., Liu J.P., Robertson E.J., Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993, 75:73-82.
25. Zapf J., Froesch E.R. Insuline-like factor I actions on somatic growth. Handbook of Physiology: The Endocrine System 1999, 663-699. Oxford University Press, New York. J.L. Kostyo (Ed.).
26. Schlechter N.L., Russell S.M., Spencer E.M., Nicoll C.S. Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:7932-7934.
27. Roberts C.T., Brown A.L., Graham D.E., Seelig S., Berry S., Gabbay K.H., et al. Growth hormone regulates the abundance of insulin-like growth factor I RNA in adult rat liver. J. Biol. Chem. 1986, 261:10025-10028.
28. Le Roith D., Bondy C., Yakar S., Liu J.L., Butler A. The somatomedin hypothesis: 2001. Endocr. Rev. 2001, 22:53-74.
29. Contreras M.A., Haq E., Uto T., Singh I., Singh A.K. Psychosine-induced alterations in peroxisomes of twitcher mouse liver. Arch. Biochem. Biophys. 2008, 477:211-218.
30. Bielawski J., Szulc Z.M., Hannun Y.A., Bielawska A. Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods 2006, 39:82-91.
31. Ono N., Nakashima K., Rittling S.R., Schipani E., Hayata T., Soma K., et al. Osteopontin negatively regulates parathyroid hormone receptor signaling in osteoblasts. J. Biol. Chem. 2008, 283:19400-19409.
32. Horn D.A., Garrett I.R. A novel method for embedding neonatal murine calvaria in methyl methacrylate suitable for visualizing mineralization, cellular and structural detail. Biotech. Histochem. 2004, 79:151-158.
33. Shanmugarajan S., Irie K., Musselwhite C., Key L.L., Ries W.L., Reddy S.V. Transgenic mice with OIP-1/hSca overexpression targeted to the osteoclast lineage develop an osteopetrosis bone phenotype. J. Pathol. 2007, 213:420-428.
34. Luzi P., Rafi M.A., Zaka M., Curtis M., Vanier M.T., Wenger D.A. Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease). Mol. Genet. Metab. 2001, 73:211-223.
35. De Gasperi R., Friedrich V.L., Perez G.M., Senturk E., Wen P.H., Kelley K., et al. Transgenic rescue of Krabbe disease in the twitcher mouse. Gene Ther. 2004, 11:1188-1194.
36. Galbiati F., Basso V., Cantuti L., Givogri M.I., Lopez-Rosas A., Perez N., et al. Autonomic denervation of lymphoid organs leads to epigenetic immune atrophy in a mouse model of Krabbe disease. J. Neurosci. 2007, 27:13730-13738.
37. Ryu J., Kim H.J., Chang E.J., Huang H., Banno Y., Kim H.H. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J. 2006, 25:5840-5851.
38. Spiegel S., Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 2003, 4:397-407.
39. Elefteriou F. Regulation of bone remodeling by the central and peripheral nervous system. Arch. Biochem. Biophys. 2008, 473:231-236.
40. Duchen L.W., Eicher E.M., Jacobs J.M., Scaravilli F., Teixeira F. Hereditary leucodystrophy in the mouse: the new mutant twitcher. Brain 1980, 103:695-710.
41. Kobayashi T., Yamanaka T., Jacobs J.M., Teixeira F., Suzuki K. The Twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease). Brain Res. 1980, 202:479-483.
42. Khan M., Haq E., Giri S., Singh I., Singh A.K. Peroxisomal participation in psychosine-mediated toxicity: implications for Krabbe's disease. J. Neurosci. Res. 2005, 80:845-854.
43. Haq E., Contreras M.A., Giri S., Singh I., Singh A.K. Dysfunction of peroxisomes in twitcher mice brain: a possible mechanism of psychosine-induced disease. Biochem. Biophys. Res. Commun. 2006, 343:229-238.
44. Strasberg P. Cerebrosides and psychosine disrupt mitochondrial functions. Biochem. Cell Biol. 1986, 64:485-489.
45. Igisu H., Nakamura M. Inhibition of cytochrome c oxidase by psychosine (galactosylsphingosine). Biochem. Biophys. Res. Commun. 1986, 137:323-327.
46. Nozawa M., Iwamoto T., Tokoro T., Eto Y. Novel procedure for measuring psychosine derivatives by an HPLC method. J. Neurochem. 1992, 59:607-609.
47. Whitfield P.D., Sharp P.C., Taylor R., Meikle P. Quantification of galactosylsphingosine in the twitcher mouse using electrospray ionization-tandem mass spectrometry. J. Lipid Res. 2001, 42:2092-2095.
48. Ida H., Umezawa F., Kasai E., Eto Y., Maekawa K. An accumulation of galactocerebroside in kidney from mouse globoid cell leukodystrophy (twitcher). Biochem. Biophys. Res. Commun. 1982, 109:634-638.
49. Karsdal M.A., Neutzsky-Wulff A.V., Dziegiel M.H., Christiansen C., Henriksen K. Osteoclasts secrete non-bone derived signals that induce bone formation. Biochem. Biophys. Res. Commun. 2008, 366:483-488.
50. Boyce B.F., Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch. Biochem. Biophys. 2008, 473:139-146.
51. Matsuo K., Irie N. Osteoclast-osteoblast communication. Arch. Biochem. Biophys. 2008, 473:201-209.
52. Singh M.K., Elefteriou F., Karsenty G. Cocaine and amphetamine-regulated transcript may regulate bone remodeling as a circulating molecule. Endocrinology 2008, 149:3933-3941.
53. Monroy M.A., Ross F.P., Teitelbaum S.L., Sands M.S. Abnormal osteoclast morphology and bone remodeling in a murine model of a lysosomal storage disease. Bone 2002, 30:352-359.
54. Hannun Y.A. Functions of ceramide in coordinating cellular responses to stress. Science 1996, 274:1855-1859.
55. Cuvillier O., Pirianov G., Kleuser B., Vanek P.G., Coso O.A., Gutkind S., et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996, 381:800-803.
56. Spiegel S., Cuvillier O., Edsall L.C., Kohama T., Menzeleev R., Olah Z., et al. Sphingosine-1-phosphate in cell growth and cell death. Ann. N. Y. Acad. Sci. 1998, 845:11-18.
57. Osawa Y., Uchinami H., Bielawski J., Schwabe R.F., Hannun Y.A., Brenner D.A. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha. J. Biol. Chem. 2005, 280:27879-27887.
58. White A.B., Givogri M.I., Lopez-Rosas A., Cao H., van Breemen R., Thinakaran G., et al. Psychosine accumulates in membrane microdomains in the brain of krabbe patients, disrupting the raft architecture. J. Neurosci. 2009, 29:6068-6077.
59. Ohlsson C., Lindahl A., Isgaard J., Nilsson A., Isaksson O.G. The dual effect theory. Handbook of Physiology: The Endocrine System 1999, 501-514. Oxford University Press, New York. J.L. Kostyo (Ed.).
60. Ernst M., Froesch E.R. Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I. Biochem. Biophys. Res. Commun. 1988, 151:142-147.
61. Hock J.M., Centrella M., Canalis E. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 1988, 122:254-260.
62. Yakar S., Rosen C.J., Beamer W.G., Ackert-Bicknell C.L., Wu Y., Liu J.L., et al. Circulating levels of IGF-1 directly regulate bone growth and density. J. Clin. Invest. 2002, 110:771-781.
63. Rosen C.J., Bilezikian J.P. Clinical review 123: anabolic therapy for osteoporosis. J. Clin. Endocrinol. Metab. 2001, 86:957-964.
64. Rosen C.J., Donahue L.R., Hunter S.J. Insulin-like growth factors and bone: the osteoporosis connection. Proc. Soc. Exp. Biol. Med. 1994, 206:83-102.
65. Rosen C.J., Kurland E.S., Vereault D., Adler R.A., Rackoff P.J., Craig W.Y., et al. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J. Clin. Endocrinol. Metab. 1998, 83:2286-2290.
66. Hegedus B., Yeh T.H., Lee da Y., Emnett R.J., Li J., Gutmann D.H. Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis. Hum. Mol. Genet. 2008, 17:2956-2966.
67. Scarborough D.E. Cytokine modulation of pituitary hormone secretion. Ann. N. Y. Acad. Sci. 1990, 594:169-187.
68. O'Connor J.C., McCusker R.H., Strle K., Johnson R.W., Dantzer R., Kelley K.W. Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology. Cell. Immunol. 2008, 252:91-110.
69. Escolar M.L., Poe M.D., Provenzale J.M., Richards K.C., Allison J., Wood S., et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N. Engl. J. Med. 2005, 352:2069-2081.
70. Cartier N., Aubourg P. Hematopoietic stem cell gene therapy in Hurler syndrome, globoid cell leukodystrophy, metachromatic leukodystrophy and X-adrenoleukodystrophy. Curr. Opin. Mol. Ther. 2008, 10:471-478.
71. Frago L.M., Paneda C., Dickson S.L., Hewson A.K., Argente J., Chowen J.A. Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. Endocrinology 2002, 143:4113-4122.
72. Aberg N.D., Brywe K.G., Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. ScientificWorldJournal 2006, 6:53-80.
73. Zaka M., Rafi M.A., Rao H.Z., Luzi P., Wenger D.A. Insulin-like growth factor-1 provides protection against psychosine-induced apoptosis in cultured mouse oligodendrocyte progenitor cells using primarily the PI3K/Akt pathway. Mol. Cell. Neurosci. 2005, 30:398-407.